Table 2.
Proportion of Cytology Results, by Human Papillomavirus (HPV) Genotype, Weighted to the Overall Population
| Type, Age | Specimens, No. (%) | Weighted Proportion |
||||
|---|---|---|---|---|---|---|
| NILM | ASC-US | LSIL | ASC-H | HSIL | ||
| HPV-16 | ||||||
| All | 4234 | 0.678 | 0.145 | 0.111 | 0.030 | 0.036 |
| ≤30 y | 3473 (82) | 0.632 | 0.164 | 0.136 | 0.033 | 0.036 |
| >30 y | 761 (18) | 0.779 | 0.104 | 0.057 | 0.024 | 0.036 |
| HPV-18 | ||||||
| All | 1461 | 0.689 | 0.155 | 0.115 | 0.018 | 0.022 |
| ≤30 y | 1105 (76) | 0.650 | 0.173 | 0.138 | 0.019 | 0.020 |
| >30 y | 356 (24) | 0.765 | 0.120 | 0.070 | 0.018 | 0.027 |
| HPV-31 | ||||||
| All | 2122 | 0.703 | 0.153 | 0.099 | 0.025 | 0.020 |
| ≤30 y | 1629 (77) | 0.655 | 0.178 | 0.119 | 0.025 | 0.023 |
| >30 y | 493 (23) | 0.793 | 0.106 | 0.060 | 0.026 | 0.015 |
| HPV-33 | ||||||
| All | 591 | 0.673 | 0.152 | 0.122 | 0.024 | 0.028 |
| ≤30 y | 445 (75) | 0.630 | 0.167 | 0.153 | 0.018 | 0.033 |
| >30 y | 146 (25) | 0.754 | 0.125 | 0.065 | 0.036 | 0.019 |
| HPV-35 | ||||||
| All | 1024 | 0.685 | 0.152 | 0.122 | 0.020 | 0.021 |
| ≤30 y | 734 (72) | 0.612 | 0.182 | 0.158 | 0.021 | 0.026 |
| >30 y | 290 (28) | 0.786 | 0.110 | 0.072 | 0.018 | 0.014 |
| HPV-39 | ||||||
| All | 2498 | 0.717 | 0.141 | 0.120 | 0.012 | 0.009 |
| ≤30 y | 2037 (82) | 0.672 | 0.161 | 0.144 | 0.013 | 0.010 |
| >30 y | 461 (18) | 0.824 | 0.094 | 0.066 | 0.010 | 0.006 |
| HPV-45 | ||||||
| All | 1130 | 0.750 | 0.135 | 0.091 | 0.015 | 0.008 |
| ≤30 y | 832 (74) | 0.708 | 0.159 | 0.108 | 0.018 | 0.008 |
| >30 y | 298 (26) | 0.818 | 0.098 | 0.065 | 0.010 | 0.009 |
| HPV-51 | ||||||
| All | 2878 | 0.656 | 0.150 | 0.159 | 0.018 | 0.016 |
| ≤30 y | 2339 (81) | 0.605 | 0.168 | 0.188 | 0.021 | 0.018 |
| >30 y | 539 (19) | 0.780 | 0.106 | 0.089 | 0.012 | 0.013 |
| HPV-52 | ||||||
| All | 2035 | 0.763 | 0.132 | 0.078 | 0.016 | 0.011 |
| ≤30 y | 1566 (77) | 0.726 | 0.154 | 0.093 | 0.014 | 0.013 |
| >30 y | 469 (23) | 0.831 | 0.091 | 0.052 | 0.020 | 0.007 |
| HPV-56 | ||||||
| All | 1709 | 0.608 | 0.161 | 0.209 | 0.012 | 0.010 |
| ≤30 y | 1240 (73) | 0.565 | 0.175 | 0.238 | 0.012 | 0.010 |
| >30 y | 469 (27) | 0.686 | 0.137 | 0.156 | 0.013 | 0.008 |
| HPV-58 | ||||||
| All | 1532 | 0.673 | 0.160 | 0.123 | 0.020 | 0.024 |
| ≤30 y | 1215 (79) | 0.641 | 0.173 | 0.140 | 0.021 | 0.025 |
| >30 y | 317 (21) | 0.750 | 0.128 | 0.083 | 0.018 | 0.021 |
| HPV-59 | ||||||
| All | 2275 | 0.759 | 0.132 | 0.094 | 0.008 | 0.007 |
| ≤30 y | 1855 (82) | 0.713 | 0.154 | 0.116 | 0.009 | 0.007 |
| >30 y | 420 (18) | 0.855 | 0.086 | 0.048 | 0.005 | 0.006 |
| HPV-68 | ||||||
| All | 815 | 0.758 | 0.130 | 0.094 | 0.014 | 0.005 |
| ≤30 y | 606 (74) | 0.676 | 0.171 | 0.129 | 0.020 | 0.005 |
| >30 y | 209 (26) | 0.863 | 0.078 | 0.049 | 0.006 | 0.005 |
Abbreviations: ASC-H, atypical squamous cells, rule out HSIL; ASC-US, atypical squamous cells of undetermined significance; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion or malignancy.